Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Yuanbao Inc Q4 2025 Earnings Call - AI Scale and Policy Tailwinds Deliver 33% Revenue Growth and Strong Margins
Yuanbao closed 2025 with clear scale: revenue up 33.1% to CNY 4.37 billion, net income up 51% to CNY 1.31 billion, and 14 consecutive profitable quarters. Management leaned heavily into AI and product...
- Q4 revenue CNY 1.18 billion, up 32.2% year-over-year; full-year 2025 revenue CNY 4.37 billion, up 33.1% YoY.
- Net income: Q4 CNY 337.4 million (+15.4% YoY); full-year CNY 1.31 billion (+51% YoY). Net margin improved to 29.9% for 2025.
- Fourteen consecutive profitable quarters, signaling sustained operating leverage and margin resilience.
- +14 more takeaways
Weibo Fourth Quarter and Fiscal Year 2025 Earnings Call - Interest‑based feed and AI video/search push to drive growth amid flat full‑year revenues and near‑term margin pressure
Weibo closed 2025 with modest top‑line momentum, a strategic product pivot, and an explicit bet on AI to reignite user engagement and ad monetization. Full‑year revenue was essentially flat at $1.76 b...
- Total revenue for FY2025 was $1.76 billion, essentially flat year‑over‑year; Q4 revenue was $473.3 million, up about 4% YoY.
- Advertising revenue for Q4 was $403.8 million, up roughly 5% YoY; full‑year ad revenue was about $1.5 billion, largely flat YoY.
- Q4 non‑GAAP operating income was $100.4 million (operating margin 21%); full‑year non‑GAAP operating income was reported at ~30% margin (management cited both $503.6m and $523.6m figures in prepared remarks).
- +12 more takeaways
Protalix BioTherapeutics Full Year 2025 Earnings Call - EU OKs Elfabrio 4-Week Dosing, Unlocks $25M Milestone and $50M Cash Runway
Protalix closed 2025 with a clear inflection point: the European Commission approved a 2 mg/kg every 4 weeks regimen for Elfabrio in adults stable on enzyme replacement therapy, triggering a $25 milli...
- European Commission approved Elfabrio 2 mg/kg every 4 weeks for adults stable on enzyme replacement therapy, expanding the EU label and creating a competitive differentiator versus rivals.
- That EU approval triggered a $25 million regulatory milestone from partner Chiesi, which Protalix says will lift cash from $30.3 million at December 31, 2025 to about $50 million by early April 2026.
- 2026 revenue guidance is $78 million to $83 million, inclusive of the $25 million milestone; management frames this as revenue growth of greater than 50% driven by more patients on Elfabrio.
- +12 more takeaways
General Mills Fiscal 2026 Q3 Earnings Call - Reinvestment Weighs on Q3, Momentum Signals Q4 Recovery
General Mills entered fiscal 2026 deliberately reinvesting behind “remarkability” across product, packaging, media, omni-channel execution and value. That reinvestment, coupled with divestitures and t...
- Company thesis: deliberate reinvestment in brand “remarkability” to restore organic growth, accepting near-term earnings pressure to improve long-term competitiveness.
- Q3 reported net sales totaled $4.4 billion, down 8%, including a 6-point headwind from divestitures and acquisitions (notably North America Yogurt).
- Organic net sales declined 3% in Q3, trailing Nielsen-measured retail sales by roughly 1.5 points, largely due to retailer inventory reductions and weather-related shipment disruptions.
- +12 more takeaways
Qfin Holdings Limited Fourth Quarter 2025 Earnings Call - Regulatory Squeeze Shrinks Volume; Risk Tightening Lifts New-Vintage Quality, Tech Business Surges
Qfin said 2025 closed under heavy regulatory and liquidity pressure that knocked down Q4 origination volumes and profits, but management pushed hard on risk controls and product diversification. Q4 lo...
- Regulatory shock drove a sharp Q4 slowdown, total loan facilitation and origination volume fell 21.8% YoY to CNY70.3 billion in Q4 2025.
- Full year 2025 total loan facilitation and origination reached CNY327.1 billion, up 1.6% YoY, showing resilience across the year despite Q4 weakness.
- Q4 non-GAAP net income dropped 45.7% YoY to CNY1.07 billion, and non-GAAP EPADS fell 39.8% YoY to CNY8.23.
- +17 more takeaways
ZTO Express Q4 2025 Earnings Call - Quality-led growth guide of 10%-13%, $1.5bn buyback financed by convertibles
ZTO reported a quarter and full year of volume-led growth while margins came under pressure. Q4 parcel volume rose 9.2% to 10.56 billion, full-year volume reached 38.5 billion, and retail parcels surg...
- Q4 2025 parcel volume 10.56 billion, up 9.2% year-over-year; full-year 2025 volume 38.5 billion, up ~13% year-over-year.
- ZTO set 2026 parcel volume guidance at 10% to 13%, implying 42.37 billion to 43.52 billion parcels, targeting growth above the State Post Bureau industry guide of 8%.
- Retail parcel segment grew 46% in 2025, with Q4 daily retail volume nearing 10 million, cited as a structural product-mix win that supports ASP and brand recognition.
- +12 more takeaways
Prudential plc FY2025 Earnings Call - Double-digit, high-quality growth and $7bn+ shareholder returns as agency overhaul continues
Prudential reported a clean, execution-driven FY2025: double-digit growth across core KPIs, stronger capital generation, and a clear path to cash returns. New business profit rose 12% to $2.8bn, gross...
- New business profit (NBP) grew 12% to $2.8 billion, with double-digit growth in every quarter of 2025.
- Gross operating free surplus generation (OFSG) rose 15% to $3.1 billion, marking the inflection point management targeted on the path to 2027 objectives.
- Dividend per share increased 15% in 2025; management guides to >10% annual DPS growth in 2026 and 2027 and additional recurring capital returns.
- +12 more takeaways
Oklo Inc. Q4 2025 Earnings Call - Platform shifts from development to deployed projects, funded by a strengthened ~$2.5B balance sheet
Oklo says 2025 was the pivot year: the company moved from lab work into parallel, on-the-ground deployments across power, fuel, and isotopes while locking in capital to push execution. Key DOE authori...
- Oklo moved from product development to active project deployment across three business units in 2025: power, fuel, and isotopes, with multiple assets under construction or advancing in parallel.
- Aurora INL is in a DOE-first authorization pathway: Oklo executed a DOE Other Transaction Agreement, received Nuclear Safety Design Agreement approval, began site work including blasting, and signed Siemens Energy for the power conversion system.
- Oklo signed a prepayment agreement with Meta to support an Aurora, Ohio campus sized up to 1.2 gigawatts, with an initial 150 megawatt phase targeted around 2030; company expects prepayment funds will support fuel procurement.
- +11 more takeaways
Andersen Group Q4 2025 Earnings Call - Strong, diversified revenue and margin expansion, GAAP loss from one-off equity restructuring
Andersen reported a clean operational beat in Q4 and full-year 2025, with revenue of $170.3 million in Q4 (+19.6% year over year) and full-year revenue of $838.7 million (+14.6%). Under the surface th...
- Q4 revenue $170.3 million, up 19.6% year over year; full-year 2025 revenue $838.7 million, up 14.6% year over year.
- GAAP net loss driven by one-off equity restructuring and IPO-related charges, about $183 million; Q4 GAAP loss was $195.9 million.
- Non-GAAP adjusted net income for 2025 was $217 million, adjusted EBITDA $226.3 million, with margin expansion versus 2024.
- +12 more takeaways
Fold Holdings, Inc. Q4 2025 Earnings Call - Credit Card Launch Is the Catalyzing Growth Engine
Fold closed a formative 2025 with product launches and a cleaned-up capital structure, but Q4 metrics were hit by a sharp Bitcoin selloff that throttled industry activity. Management frames the newly ...
- Fold says Q4 weakness was driven by Bitcoin volatility, with BTC sliding from $124,000 to $87,000 by year-end and to $60,000 in February 2026, a decline that reduced user engagement across the platform.
- The Fold Bitcoin Rewards Credit Card is officially live, being underwritten to internal employees first, and will roll out down a wait list of more than 80,000 users in staged waves tied to fraud and risk gate checks.
- Card economics: flat, unlimited 1.5% back on all purchases, with up to 4% back for qualifying activity (primarily buying or selling Bitcoin on Fold); paying the card with Bitcoin raises the minimum to 2% back.
- +12 more takeaways